Amid Onpattro launch, Alnylam raises $387.5M

Just over five months after gaining its first-ever approval of an RNAi therapy, Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) has raised $387.5

Read the full 207 word article

User Sign In